atenolol has been researched along with Premenstrual Syndrome in 2 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Parry, BL | 2 |
| Rosenthal, NE | 2 |
| James, SP | 1 |
| Wehr, TA | 2 |
| Tamarkin, L | 1 |
2 trials available for atenolol and Premenstrual Syndrome
| Article | Year |
|---|---|
Atenolol in premenstrual syndrome: a test of the melatonin hypothesis.
Topics: Affect; Atenolol; Female; Humans; Melatonin; Premenstrual Syndrome; Psychiatric Status Rating Scales | 1991 |
Treatment of a patient with seasonal premenstrual syndrome.
Topics: Adult; Atenolol; Clinical Trials as Topic; Female; Hospitalization; Humans; Melatonin; Phototherapy; | 1987 |